A stem cell-based flow cytometry assay to predict post-transplantation relapse in patients with myelodysplastic syndromes with excess blasts: a prospective study.

Published

Research record: A stem cell-based flow cytometry assay to predict post-transplantation relapse in patients with myelodysplastic syndromes with excess blasts: a prospective study.

Published in Transplant Cell Ther; first publication date 2026-10-14. PMID 42874800.

This literature update records publication metadata from Europe PMC. Consult the original publication for its methods, findings and limitations.

Read the original publication on PubMed

Review and references

Source

Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.

Published

2026-10-14

Updated

2026-10-20

Disclaimer

professional use